Renal Functions in Preeclamptic Pregnant Women Using Neutrophil Gelatinase-associated Lipocalin (NGAL) and Standard Renal Function Tests
NCT07015359
Acute Kidney Failure, Acute Kidney Injury
Ankara, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT06857188
The assessment of AI -based prediction models in detecting AKI early in critically ill patients. Specifically, the aim is to evaluate the model's ability to predict the onset of AKI before it clinically manifests allowing for early interventions
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Acute kidney injury (AKI) is the most severe, common, and life-threatening complication in hospitalized patients and is associated with high morbidity and mortality rates . It has been demonstrated that AKI affects approximately 30-60% of critically ill patients, especially those in the intensive care unit (ICU) . Despite the recent advances in clinical care and dialysis technology, the occurrence of AKI in ICU patients has a mortality rate of up to 50%, which is 1.5 to 2-fold to that of ICU patients without AKI . However, if detected and managed promptly, interventions guided by established recommendations, such as those provided by KDIGO, may mitigate the risk of further deterioration in AKI patients . Therefore, identifying individuals at high risk of AKI is vital for managing critically ill patients.
Artificial intelligence (AI) and machine learning (ML) represent emerging technologies that could use large amounts of health-related data to help physicians make better clinical decisions and improve individual health outcomes. While serum creatinine (Scr) and urine output serve as diagnostic criteria for AKI, delays in their detection may occur. Therefore, early identification of patients at risk of developing AKI is crucial to create a window for preventive interventions and mitigate the risk of further deterioration. Several previous studies have developed various ML-based models to predict AKI in critically ill patients due to the potential benefits of early detection of AKI . It is critical to remove the mystery surrounding ML since doing so makes it simpler for doctors to comprehend the reasoning behind ML . In order to explain why ML makes the choices it does, a new field called Explainable AI (XAI) has emerged. Two of the most popular methods for explaining are Local Interpretable Model-Agnostic Explanation (LIME) and Shapley Additive Explanation (SHAP) . Novel interpretable approaches have been effectively utilized to explain ML models for preventing hypoxemia during surgery [10], predicting mortality in sepsis and AKI , predicting the occurrence of AKI following cardiac surgery , and predicting antibiotic resistance .
To the best of our knowledge, the reliability and robustness of explanatory techniques for detecting AKI in critically sick patients have rarely been studied. Therefore, the present study was conducted to construct an ML approach for the early prediction of AKI in ICU patients and to apply XAIs to make ML more transparent and interpretable.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
assessment of the ability of the AI based model to detect AKI in critically ill patients by evaluating the model ability to predict the onset of early AKI before it is clinically manifested for early interventions . this will be done by generating an AKI risk score by the model for each patient. Outcomes are tracked and the model is updated periodically based on new patient data to improve accuracy and reliability
Time frame: 1 year
assessment of clinical outcomes ( e.g, time to intervention , AKI severity , RRT use, and patient mortality ) impact on ICU (length of ICU stay)
Contact information is provided by the study sponsor or research team.
Kareem Sherif Mosabah, Assistant lecturer
CONTACT
Radwa Awad Abd El Hafez, lecturer
CONTACT
Assiut University
Other
Role of Artificial Intelligence in the Prediction of AKI in Critically Ill Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07015359
Acute Kidney Failure, Acute Kidney Injury
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07645365
Acute Kidney Failure, Acute Kidney Injury
Antalya, konyaaltı, Turkey (Türkiye)
View Trial DetailsNCT07132619
Acute Kidney Failure, Acute Kidney Injury
Istanbul, Kartal, Turkey (Türkiye)
View Trial DetailsNCT07631221
Acute Kidney Failure, Acute Kidney Injury
Buenos Aires, Argentina
View Trial Details